Meningitis Treatment Market to Reach US$ 234.8 Million by 2034, Expanding at 4.1% CAGR
The global meningitis treatment market represents a critical segment of the pharmaceutical and healthcare industry, driven by the urgent medical need to manage and treat life-threatening infections of the protective membranes covering the brain and spinal cord. Meningitis can be caused by bacterial, viral, fungal, or parasitic infections, with bacterial meningitis being the most severe and...